INTRODUCTION {#S2}
============

Adaptive immunity requires selected T and B lymphocytes to produce differentiated cellular descendants (effector cells and plasma cells) while self-renewing the less differentiated fate. The initial cell divisions of a selected CD8+ T cell appear to yield a more activated, proliferative, and differentiation-prone daughter cell alongside a less activated and more quiescent sibling cell ([@R4]; [@R19], [@R20]; [@R27]; [@R30]). After 3 or 4 divisions, the more activated progenitor cell appears to give rise to an irreversibly determined effector cell with *de novo* silencing of TCF1 expression, alongside a self-renewing progenitor cell, which is more anabolic and activated than a quiescent memory cell, but maintains TCF1 expression and the bipotency to yield daughter cells with discordant silencing of TCF1 ([@R1]; [@R19], [@R20]; [@R26]).

Dividing B cell progenitors likewise appears to give rise to an irreversibly determined plasmablast with *de novo* silencing of Pax5 expression, alongside a self-renewing progenitor cell that retains the bipotency to yield daughter cells with discordant silencing of Pax5 ([@R1]; [@R19]). A hallmark of the cell divisions giving rise to sibling cells with discordant silencing of Pax5 and TCF1 is the discordant transmission of phosphatidylinositol 3-kinase (PI3K) signaling, as indexed by inactivation of FoxO1 through its nuclear displacement ([@R19]). Herein, examination of the subcellular localization of antigen receptor-associated class I PI3K activity revealed its asymmetric positioning prior to cytokinesis. A PI3K-mediated polarity mechanism, operative before and during cell division, is apparently responsible for unequal PI3K-driven nutrient uptake and differentiation between sibling cells.

RESULTS {#S3}
=======

Asymmetric Division of Functional PI3K Activity in CD8+ T Cells {#S4}
---------------------------------------------------------------

PI3K activation of lymphocytes results from antigen and costimulatory receptor signaling ([@R10]; [@R11]; [@R13]; [@R16]; [@R21]). Additionally, endocytosis of antigen receptors has emerged as a critical mechanism for maximal activation of T and B lymphocytes, including adequate anabolic induction and proliferation ([@R5]; [@R32]; [@R33]). We, therefore, used confocal microscopy to image P14 CD8+ T cells that were activated *in vitro* for 3 to 4 days with gp33 peptide and antigen-presenting cells (APCs). At this point, activated T cells had undergone several cell divisions and begun to repress TCF1 ([Figure S1A](#SD1){ref-type="supplementary-material"}). In contrast to unstimulated CD8+ T cells, which contained symmetrical, concentric, plasma membrane-localized CD3, activated T cells exhibited CD3 staining that was polarized to the microtubule organizing center (MTOC) and more internalized than in resting cells ([Figure 1A](#F1){ref-type="fig"}). Using a monoclonal antibody that detects phosphatidylinositol (3,4,5)-trisphosphat (PIP~3~), a lipid signaling intermediate generated by receptor-associated class I PI3K enzymatic activity, we found that class I PI3K activity (PIP~3~) co-localizes with CD3 at the MTOC of dividing cells and that it remains polarized at one end of the mitotic spindle in metaphase cells ([Figure 1B](#F1){ref-type="fig"}).

To determine whether the asymmetry of PI3K activity might have functional consequences, we examined the localization of Glut1, the major inducible glucose transporter of lymphocytes ([@R3]; [@R23]). Glut1 is up-regulated upon T cell activation, and PI3K activity is essential for trafficking Glut1 from recycling endosomes to the plasma membrane ([@R15]; [@R31]). In activated interphase cells, Glut1 was primarily found in discrete intracellular puncta, largely polarized to the MTOC, with some transporter also detectable at the plasma membrane ([Figure 1C](#F1){ref-type="fig"}). In metaphase, Glut1 remained asymmetric at one end of the mitotic spindle ([Figure 1C](#F1){ref-type="fig"}). Consistent with the role of aerobic glycolysis in effector determination ([@R1]; [@R3]; and references therein), cells expressing higher levels of surface Glut1 were also enriched in TCF1-silenced effector cells ([Figure 1D](#F1){ref-type="fig"}). Asymmetric polarization of PI3K activity and glucose transporter abundance at metaphase could therefore represent a means to bias cell metabolism and cell fate between incipient sibling cells during and after cytokinesis.

Asymmetric Division of Functional PI3K Activity in B Cells {#S5}
----------------------------------------------------------

Modeled differentiation of B cells using lipopolysaccharide (LPS) stimulation *in vitro* recapitulates *in vivo* responses to immunization, including PI3K-dependent, intra-divisional bifurcation of self-renewing Pax5-expressing B cells and differentiated Pax5-silenced plasmablasts ([Figure S1B](#SD1){ref-type="supplementary-material"}) ([@R1]; [@R19]). LPS-stimulated B cells transmit their activating signals, including PI3K, through immunoglobulin M (IgM) and CD19 ([@R16]; [@R28]). Compared to resting B cells, which contained concentric, plasma membrane-localized IgM, dividing B cells activated with LPS for 3 days contained predominantly intracellular IgM, which was polarized to the MTOC ([Figure 2A](#F2){ref-type="fig"}). Asymmetry of internalized IgM was maintained in dividing B cells throughout the cell cycle.

We found that LPS-stimulated B cells, like antigen-activated T cells ([Figure 1C](#F1){ref-type="fig"}), exhibited asymmetric localization of Glut1 throughout the cell cycle ([Figure 2B](#F2){ref-type="fig"}), and that cells expressing higher levels of surface Glut1 were enriched in Pax5-silenced plasmablasts ([Figure 2C](#F2){ref-type="fig"}). The reagent that detects PIP~3~, a mouse IgM monoclonal antibody, was used to stain class-switched, IgM-negative memory B cells that had been activated with LPS, a condition that recapitulates bifurcation into Pax5-expressing and Pax5-silenced cells after 3 to 4 divisions ([Figure S1B](#SD1){ref-type="supplementary-material"}). Co-staining of Glut1 and PIP~3~ in activated, class-switched memory B cells revealed concordant asymmetry of PI3K activity and Glut1. Sites of PI3K-transmitting receptor polarization (CD19) were often denser in membrane staining ([Figure S2A](#SD1){ref-type="supplementary-material"}), prompting us to consider whether receptor polarity would be a universal finding under these conditions. Examination of CD98, a receptor implicated in asymmetric mammalian target of rapamycin (mTOR) induction in T cells ([@R27]; [@R30]), revealed that asymmetric localization of CD3 was not accompanied by coordinate asymmetry of CD98 ([Figure S2B](#SD1){ref-type="supplementary-material"}). Co-localization of signaling receptors, PI3K activity, and glucose transporter trafficking might thus be a conserved mechanism to generate clonal diversification of lymphocytes.

Asymmetry of PI3K Signaling Governed by a PI3K-Mediated Polarity Pathway {#S6}
------------------------------------------------------------------------

In addition to roles in signaling to metabolic adaptation, gene expression, and membrane trafficking, PI3K pathways play a conserved role in several forms of cellular symmetry breaking, often in conjunction with actin and microtubule cytoskeletal rearrangements ([@R2]; [@R9]; [@R24]; [@R25]; and references therein). To test whether PI3K-dependent polarity pathways control asymmetry of antigen receptors and Glut1, we performed transient pharmacological inhibition experiments. For interphase cells, a decentralization score was calculated based on the proximity of the molecule of interest to the MTOC (see Experimental Procedures). Compared to cells activated in the absence of an inhibitor, CD3 became substantially decentralized away from the MTOC in interphase cells as well as becoming more symmetrical in metaphase cells when the PI3K inhibitor LY294002 was present ([Figures 3A and 3B](#F3){ref-type="fig"}). Consistent with observations that lipid-based (including PI3K-mediated) polarity pathways typically interact with regulated cytoskeletal re-arrangements, we found that inhibition of actin-based myosin II motors with Blebbistatin resulted in decentralization of both CD3 and PIP~3~ staining away from the MTOC ([Figures 3A and 3C](#F3){ref-type="fig"}).

In view of the importance of class I PI3K molecules, particularly PI3Kδ, in antigen receptor signaling ([@R11]; [@R12]; [@R13]; [@R21]), we also tested the effect of idelalisib, a PI3Kδ-specific inhibitor, and pictilisib, a pan-class I PI3K inhibitor on T cell fate, nutrient utilization, and polarity. Like LY294002, the more specific inhibition resulted in defective silencing of TCF1, reduced cell surface trafficking of Glut1, diminished glucose uptake ([Figure 3D](#F3){ref-type="fig"}), and defective CD3 polarity, the latter appearing more severe in interphase cells than metaphase cells ([Figure 3E](#F3){ref-type="fig"}). Pictilisib also resulted in loss of PIP~3~ staining, as assessed by microscopy ([Figures S3A](#SD1){ref-type="supplementary-material"}) and flow cytometry ([Figure S3B](#SD1){ref-type="supplementary-material"}), which, along with the dissimilar pattern of PIP~2~ staining ([Figure S3C](#SD1){ref-type="supplementary-material"}), underscores the specificity of the observed polarity in class I PI3K activity. In activated dividing B cells, addition of the inhibitor LY294002 also disrupted polarity and asymmetry of internalized IgM, Glut1, and CD19 ([Figures 3F, 3G, 3H](#F3){ref-type="fig"}, and [S4](#SD1){ref-type="supplementary-material"}). A PI3K-associated polarity mechanism may thus be responsible for organizing asymmetric distribution of receptors that transduce PI3K signaling to nutrient utilization, anabolism, gene expression, and membrane trafficking.

Asymmetric PI3K Signaling and Glut1 Inheritance In Vivo {#S7}
-------------------------------------------------------

To determine whether subcellular compartmentalization and asymmetry of PI3K signaling is a physiological occurrence *in vivo*, we examined CD8+ T cells from mice infected with *Listeria monocytogenes (L. monocytogenes)*. TCR transgenic P14 CD8+ T cells expressing a *Tcf7*^GFP/+^ reporter ([@R6]) were transferred intravenously to naive recipient mice, followed by infection of recipients with *L. monocytogenes* expressing the LCMV peptide gp33 (LM-gp33). Spleens were harvested at day 4 to 5 post-infection, when the majority of activated P14 cells had undergone 4 or more rounds of cell division ([@R20]). *Tcf7*-GFP^hi^ cells were sorted for analysis by confocal immunofluorescence microscopy. Similar to cells activated *in vitro* ([Figures 1](#F1){ref-type="fig"} and [3](#F3){ref-type="fig"}), we found that CD3, PIP~3~, and Glut1 were concordantly co-localized at the MTOC and at one end of the spindle pole during interphase and metaphase, respectively ([Figure 4](#F4){ref-type="fig"}). These results support a model wherein CD8+ T cells undergoing asymmetric fate determination during later cell divisions *in vivo* possess coordinated asymmetry of endocytosed antigen receptors, class I PI3K activity, and facultative glucose transporter trafficking.

DISCUSSION {#S8}
==========

Genetic studies yielding incomplete phenotypes have led to uncertainty about the role of the evolutionarily conserved PAR polarity network in lymphocyte asymmetric division (reviewed by [@R25]). In dividing lymphocytes, class I PI3K activity, triggered by antigen and costimulatory signals and indexed by PIP~3~ production, appears to be asymmetrically positioned alongside both the receptors that initiate class I PI3K activity and downstream protein targets, such as Glut1, that are trafficked by class I PI3K activity. The asymmetric localization of receptors that trigger PI3K activity appears to be at least partly dependent on class IA PI3Kδ activity, which also couples glucose uptake with silencing of TCF1, the hallmark of irreversible effector cell differentiation ([@R19], [@R20]; [@R26]). Although PI3K activity may be dispensable for glucose uptake in differentiated killer T cells ([@R22]), the present results are consistent with prior evidence that PI3K signaling is required for glucose uptake and Glut1 trafficking in newly differentiating T cells ([@R10]; [@R15]). The convergence of PI3K-dependent metabolic, transcriptional, and cell-polarity functions during cell division appears to form a mechanism that ensures self-renewal accompanies differentiation of lymphocytes.

Spatially segregated class I PI3K activity and accompanying cytoskeletal rearrangement is an evolutionarily conserved response to guidance cues for directed migration, axon outgrowth of neurons, immunological synapsis, apico-basal polarity, and asymmetric epithelial progenitor division ([@R2]; [@R7]; [@R9]; [@R12]; [@R13]; [@R18], [@R17]; [@R24]; [@R25]). Following T lymphocyte activation, focal PI3K activity and actin remodeling co-localize at the immune synapse ([@R12]; [@R13]; [@R18]; [@R29]). Receptor-induced actin remodeling, PI3K activity, and their associated GTPases and exchange factors can act in a self-reinforcing feedback loop to create a domain of cytoskeletal-driven polarity ([@R2]; [@R17]). Although some features of immune synapsis may be PI3K-independent ([@R13]), focal actin remodeling at the synapse is both PI3Kδ-dependent ([@R12]; [@R18]) and critical in establishing polarity of synaptic antigen receptors (reviewed by [@R17]).

Insofar as endocytosed antigen receptors propagate anabolic activation of lymphocytes ([@R5]; [@R32]; [@R33]), membrane-trafficking events mediated by class II and III PI3K signaling could potentially cooperate with class-I-initiated polarity to maintain asymmetry through cell division. Consistent with this hypothesis, inhibition of class IA PI3Kδ perturbed CD3 polarity more severely in cells in interphase than in metaphase ([Figure 3E](#F3){ref-type="fig"}). Some asymmetric divisions in flies result from polarized endocytic trafficking of receptor components independently of the PAR polarity network ([@R8]). Whether other PI3K isoforms and classes, mTOR activity, and PAR polarity proteins play complementary or downstream roles to class I PI3K in asymmetric lymphocyte division will require further investigation ([@R9]; [@R14]; [@R24]; [@R27]; [@R30]).

EXPERIMENTAL PROCEDURES {#S9}
=======================

Mice {#S10}
----

All animal work was conducted in accordance with the Institutional Animal Care and Use Guidelines of Columbia University in specific pathogen-free conditions. Male and female mice were used, all between 6 and 8 weeks of age. Strains used include C57BL/6 (wild-type), P14 TCR transgenic (P14) recognizing LCMV peptide gp33-41/Db, *TCF7^GFP/+^* reporter ([@R6]), and homozygous myc-Glut1 mice containing an exofacial (surface) myc tag in the gene encoding the Glut1 transporter ([@R23]).

Lymphocyte Activation {#S11}
---------------------

Wild-type B cells, myc-tagged Glut1 B cells, or myc-tagged Glut1 CD8+ T cells were enriched from splenocytes using magnetic bead negative selection kits (Miltenyi Biotec). B cells were stimulated with 20 μg/mL LPS, and polyclonal CD8+ T cells were stimulated with plate-bound anti-CD3/CD28 (1 μg/mL) supplemented with 100 IU/mL interleukin-2 (IL-2) ([@R1]). For P14 CD8+ T cells, bulk splenocytes were activated with gp33 peptide (1 μg/mL) as previously described ([@R20]). For switched memory B cells, CD23+, IgD−, IgM−, and lineage-negative (CD4, CD8, and Gr1) cells were sorted from bulk splenocytes and then stimulated with LPS (20 μg/mL). Lymphocytes were labeled with CellTrace Violet (CTV) prior to stimulation. Where indicated, cells were treated with the following drugs: idelalisib (GS-1101, Selleckchem, 1 μM), pictilisib (GDC-0941, Selleckchem, 1 μM), LY294002 (Cell Signaling Technology, 2.5--5 μM), and Blebbistatin (Abcam, 20 μM).

Infectious Challenge {#S12}
--------------------

For *in vivo* experiments, 1 ×10^6^ to 3 ×10^6^ Tcf7-GFP reporter P14 CD8+ T cells were adoptively transferred intravenously (i.v.) into allotype-disparate C57BL/6 wild-type mice, which were subsequently infected with 5 × 10^3^ colony-forming units (CFUs) of *L. monocytogenes* expressing gp33 (LM-gp33) via i.v. injection. Spleens were harvested at day 4 to 5 of infection, and CD8+ T cells were then MACS-enriched for cell sorting of transferred, Tcf7-GFP+ P14 cells.

Flow Cytometry {#S13}
--------------

Single-cell suspensions were prepared and stained as previously described ([@R20]). Antibodies used include rabbit anti-myc tag (71D10, Cell Signaling Technology), mouse anti-myc tag (4A6, Millipore), TCF1 (C63D9, Cell Signaling Technology), Pax5 (1H9, eBioscience), IgM (Il/41, eBioscience), IgD (11-26c.2a, BioLegend), CD23 (B3B4, eBioscience), CD4 (RM405, BioLegend), CD8α (53-6.7, eBioscience), and Gr1 (RB6-8C5, BD PharMingen). Glucose uptake was determined by staining with the fluorescent glucose analog 2-NBDG (Cayman, 100 μM) in glucose-free RPMI.

Confocal Microscopy {#S14}
-------------------

Immunofluorescence microscopy was performed as described ([@R19]). Antibodies included α-tubulin (YOL1/34, Abcam), β-tubulin (AA2, Sigma), CD19 (1D3, BD Pharmingen), CD98 (RL388, BioLegend), IgM (II/41, eBioscience), PIP~3~ (RC6F8, Thermo Fisher Scientific), PIP~2~ (2C11, Abcam), Glut1 (EPR3915, Abcam), CD3ε (ebio500A2, eBioscience), anti-mouse-IgM (Thermo Fisher Scientific), and Alexa-Fluor-conjugated secondary antibodies (Thermo Fisher Scientific). Metaphase cells were identified by the presence of two MTOCs with opposed spindle poles. Cytokinetic cells were identified by the presence of a tubulin-containing bridge. To quantify polarity in inter-phase cells, a decentralization score was calculated based on the proximity of fluorescent puncta to the MTOC. Cells were divided into 6 equal sectors, and each sector that contained at least 1 fluorescent punctum was counted toward the decentralization score. The sector containing the MTOC is worth 0 points; the sector directly opposite the MTOC is 3 points; the two sectors adjacent to the MTOC sector are 1 point each; the two sectors adjacent to the sector opposite the MTOC are 2 points each. Cells with fluorescent puncta entirely localized to the MTOC received a score of 0, whereas cells with decentralized puncta had higher scores. For quantification of asymmetry, fluorescent signal was thresholded to remove background, and integrated fluorescence density in each nascent daughter cell or half the metaphase cell was calculated. Asymmetry was calculated as (fluorescence daughter 1 + fluorescence daughter 2)/(fluorescence daughter 1 + fluorescence daughter 2), with values over 0.2 considered asymmetric.

Statistical Analyses {#S15}
--------------------

Statistical significance between experimental groups was assessed using GraphPad Prism software (version 7). Unless indicated, data were reported as mean ± SEM. All t tests were two-tailed. Parametric and non-parametric tests were used, as specified in each figure legend. Significance cutoffs and post-test corrections are stated in each figure legend. Not significant (n.s.); \*p \< 0.05; \*\*p \< 0.01; \*\*\*p \< 0.001; and \*\*\*\*p \< 0.0001.
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![Asymmetric Division of Functional PI3K Activity in CD8+ T Cells\
(A) Confocal immunofluorescence (IF) microscopy of CD3 localization in unstimulated (N = 16) or gp33 peptide-stimulated interphase P14 CD8+ T cells activated for 3 days (N = 23).\
(B) Top: CD3 and PIP~3~ localization in interphase and metaphase P14 blasts at day 3 post-activation. Bottom left: quantification of CD3 and PIP~3~ asymmetry in metaphase cells. \*\*\*\*p \< 0.001. Chi-square test with Bonferroni correction. Bottom right: among PIP~3~ asymmetric cells, proportion with CD3 asymmetric concordant (same MTOC), CD3 asymmetric discordant (opposite MTOC), or CD3 symmetric localization.\
(C) Left: Glut1 localization in interphase and metaphase P14 blasts. Right: quantification of Glut1 asymmetry in metaphase cells. \*\*\*\*p \< 0.001. Fisher's exact test.\
(D) CD8+ T cells expressing myc-tagged Glut1 were stimulated with anti-CD3/CD28 + IL-2 for 3.5 days. Left: surface Glut1 versus cell division, gated for high and low populations. Middle: TCF1 expression versus cell division within surface Glut1-high and -low populations. Right: quantification of TCF1-low population frequency. \*p \< 0.05. Paired t test.\
For all panels, dashed blue line denotes an asymmetry cutoff value of 0.2, and scale bars are 5 μm.\
See also [Figures S1 and S2](#SD1){ref-type="supplementary-material"}.](nihms937936f1){#F1}

![Asymmetric Division of Functional PI3K Activity in B Cells\
(A) Confocal IF microscopy analysis of IgM localization in LPS-stimulated B cells at day 3 post-activation. Left: IgM localization in unstimulated (resting) interphase (N = 16) or LPS-stimulated interphase and mitotic B cells (N = 19). Right: quantification of IgM asymmetry in metaphase and cytokinetic cells. \*\*\*\*p \< 0.0001; \*\*\*p \< 0.001. Fisher's exact test.\
(B) Left: Glut1 localization in LPS-stimulated mitotic B cells at indicated stages of the cell cycle. Right: quantification of Glut1 asymmetry in metaphase cells. \*\*\*\*p \< 0.0001. Fisher's exact test.\
(C) B cells expressing myc-tagged Glut1 stimulated with LPS for 3.5 days. Left: surface Glut1 versus cell division, gated for high and low populations. Middle: Pax5 expression versus cell division within the surface Glut1-high and -low populations. Right: quantification of Pax5-low population frequency. \*p \< 0.05. Paired t test.\
(D) Class-switched (IgM negative), resting memory B cells stimulated with LPS and analyzed by IF microscopy on day 3 post-activation. Left: subcellular localization of PIP~3~ and Glut1 in interphase and metaphase blasts. Middle: quantification of PIP~3~ and Glut1 asymmetry in metaphase cells. \*\*\*\*p \< 0.0001; \*\*\*p \< 0.001. Chi-square test with Bonferroni correction. Right: among cells with asymmetric PIP~3~, proportion of asymmetric concordant, asymmetric discordant, and symmetric Glut1 localization.\
See also [Figures S1 and S2](#SD1){ref-type="supplementary-material"}.](nihms937936f2){#F2}

![PI3K-Dependent Polarity Control of Asymmetric PI3K Signaling\
(A) P14 CD8+ T cells activated as in [Figure 1](#F1){ref-type="fig"} and treated with indicated drugs to perturb polarity. Left: CD3 localization in cells treated with no drug, LY294002, or myosin II inhibitor (Blebbistatin). Lower right: CD3 decentralization score. \*\*p \< 0.01; \*p \< 0.05. Kruskal-Wallis non-parametric test.\
(B) CD3 localization in metaphase cells treated with no drug or LY294002. Lower panel: quantification of CD3 asymmetry. \*\*p \< 0.01. Fisher's exact test.\
(C) PIP~3~ localization in interphase CD8+ T cells treated with no drug or Blebbistatin. Lower panel: PIP~3~ decentralization score. \*\*\*p \< 0.001. Mann-Whitney U test.\
(D) Class I PI3K-driven TCF1 repression and facultative glucose transporter function. Upper row: cell division and TCF1 expression at day 4 in the absence or presence of idelalisib (PI3Kδ inhibitor), pictilisib (pan-class I PI3K inhibitor), or LY294002 (pan-PI3K inhibitor). Lower left: quantification of surface Glut1 in P14 CD8+ T cells 3 days post-activation in the absence or presence of indicated inhibitors. Lower right: uptake of fluorescent glucose analog 2-NBDG in the absence or presence of the indicated inhibitors. \*p \< 0.05; \*\*p \< 0.01; \*\*\*\*p \< 0.0001. One-way ANOVA.\
(E) Left: CD3 localization in interphase CD8+ T cells activated in the absence or presence of idelalisib or pictilisib. Middle: CD3 decentralization score. \*\*p \< 0.01; \*\*\*p \< 0.001. Kruskal-Wallis non-parametric test. Far right: quantification of CD3 asymmetry in metaphase CD8+ T cells activated in the absence or presence of idelalisib. p = 0.05. Mann-Whitney U test.\
(F and G) Representative IF images and quantification of IgM asymmetry in LPS-activated B cells in the absence or presence of LY294002 at indicated stages of cell division. \*p \< 0.05 by Fisher's exact test.\
(H) Representative images of Glut1 localization in interphase LPS-stimulated B cells in the absence or presence of LY294002. Decentralization score of indicated groups quantified beneath microscopy. \*\*p \< 0.01. Mann-Whitney U test.\
All error bars within this figure represent mean ± SEM. See also [Figures S3 and S4](#SD1){ref-type="supplementary-material"}.](nihms937936f3){#F3}

![Asymmetric PI3K Activity Organizing Unequal Inheritance of Antigen Receptor and Glucose Transporter *In Vivo*\
(A) Polarization and asymmetric inheritance of CD3 and PIP~3~ in interphase and metaphase P14 CD8+ T cells *in vivo* during L. monocytogenes infection. FACS-sorted TCF7-GFP reporter P14 CD8+ T cells at day 4 to 5 post-infection analyzed by IF microscopy. Left: PIP~3~ and CD3 localization in interphase and metaphase blasts. Right: quantification of PIP~3~ and CD3 asymmetry in metaphase cells. \*\*\*\*p \< 0.0001. Chi-square test with Bonferroni correction.\
(B) Polarization and asymmetric inheritance of Glut1 *in vivo*. Left: Glut1 localization in interphase and metaphase P14 CD8+ T cells processed as in (A). Right: quantification of Glut1 asymmetry in metaphase cells. \*\*\*\*p \< 0.0001. Fisher's exact test.\
(C) Concordant polarity of PIP~3~ and Glut1 *in vivo*. Left: PIP~3~ and Glut1 localization in metaphase P14 CD8+ T cells. Middle: quantification of PIP~3~ and Glut1 asymmetry in metaphase cells. \*\*\*\*p \< 0.0001. Chi-square test with Bonferroni correction. Right: proportion of PIP~3~ asymmetric cells with Glut1 asymmetric concordant (same MTOC), Glut1 asymmetric discordant (opposite MTOC), or Glut1 symmetric localization.](nihms937936f4){#F4}

###### Highlights

-   Class I PI3K activity is asymmetrically polarized in activated, mitotic lymphocytes.

-   Receptors upstream of PI3K activity polarize via a PI3K-dependent polarity mechanism.

-   Focal PI3K activity correlates with unequal traffic of inducible glucose transporters.

-   PI3K-driven differentiation and asymmetry merge to enable divergent sister cell fate.
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